Charité - Universitätsmedizin Berlin

Sequential Therapies in Well-Differentiated Gastrointestinal Neuroendocrine Tumors G3 (NET G3): Platinum-Based vs. Platinum-Free Regimens (2018) Dal Buono A, Merola E, Delle Fave G, Wiedenmann B, Pavel ME Conference contribution Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical Trial (2018) Pavel M, Benavent M, Perros P, Srirajaskanthan R, Warner RRP, Kulke MH, Anthony LB, et al. Conference contribution Systemic Anti-Cancer Therapies in Neuroendocrine Tumor Patients Impair Nutritional Status (2018) Pevny S, Maasberg S, Karber M, Knappe-Drzikova B, Weylandt KH, Pavel ME, Wiedenmann B, et al. Conference contribution The role of donor clonal hematopoiesis in allogeneic hematopoietic stem cell transplantation (2018) Frick M, Chan W, Arends CM, Hablesreiter R, Halik A, Blau O, Heuser M, et al. Conference contribution Osteoimmunology-IMMUNOBONE : Regulation of bone by inflammation (2018) Rauner M, Buttgereit F, Distler J, Garbe AI, Herrmann M, Hofbauer L, Hoffmann M, et al. Journal article RITUXIMAB IN SYSTEMIC SCLEROSIS : SAFETY AND EFFICACY DATA FROM THE EUSTAR NETWORK (2018) Elhai M, Distler O, Smith V, Matucci-Cerinic M, Alegre-Sancho JJ, Truchetet ME, Braun-Moscovici Y, et al. Conference contribution Racial differences in SSc disease presentation: a European scleroderma trials and research group (EUSTAR) study (2018) Jaeger VK, Siegert E, Hachulla E, Airo P, Valentini G, Matucci-Cerinic M, Scorza R, et al. Conference contribution Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves (2018) Kuramatsu J, Sembill J, Gerner S, Sprügel M, Hagen M, Röder S, Endres M, et al. Journal article Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup (2018) Johann PD, Bens S, Oyen F, Wagener R, Giannini C, Perry A, Raisanen JM, et al. Journal article Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians (2018) Gaß P, Untch M, Mueller V, Moebus V, Thomssen C, Häberle L, Erber R, et al. Journal article